![](/img/cover-not-exists.png)
Gemcitabine plus nab-paclitaxel until progression or alternating with FOLFIRI.3, as first-line treatment for patients with metastatic pancreatic adenocarcinoma: The Federation Francophone de Cancérologie Digestive-PRODIGE 37 randomised phase II study (FIRGEMAX)
Rinaldi, Yves, Pointet, Anne-Laure, Khemissa Akouz, Faiza, Le Malicot, Karine, Wahiba, Bidaut, Louafi, Samy, Gratet, Alain, Miglianico, Laurent, Laharie, Hortense, Bouhier Leporrier, Karine, Thirot BiVolume:
136
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2020.05.018
Date:
September, 2020
File:
PDF, 571 KB
2020